Meeting
2018 ASCO Annual Meeting
Upper tract urothelial carcinoma is non-basal and T-cell depleted.
Authors
Panagiotis J. Vlachostergios
Division of Hematology & Medical Oncology, Weill Cornell Medical College & New York-Presbyterian Hospital, New York, NY
Panagiotis J. Vlachostergios , Brian D. Robinson , Bhavneet Bhinder , Rohan Bareja , Kyung Park , Peyman Tavassoli , Scott T. Tagawa , David M. Nanus , Juan Miguel Mosquera , Douglas Scherr , Mark A. Rubin , Olivier Elemento , Bishoy Faltas
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary (Nonprostate) Cancer
Track
Genitourinary Cancer—Kidney and Bladder
Sub Track
Bladder Cancer
Citation
J Clin Oncol 36, 2018 (suppl; abstr 4525)
DOI
10.1200/JCO.2018.36.15_suppl.4525
Abstract #
4525
Poster Bd #
351
Abstract Disclosures
Funded by Conquer Cancer
Similar Posters
Poster
2024 ASCO Annual Meeting
Comparing the somatic, germline, and immune landscapes of upper tract urothelial carcinoma (UTUC) and UC of the bladder (UCB).
First Author: Kit L. Yuen
Poster
2020 ASCO Virtual Scientific Program
Genomic landscape and immune phenotype of malignant pleural mesothelioma.
First Author: Meera Patel
Poster
2019 Genitourinary Cancers Symposium
Non-urothelial bladder cancer: Genomic alterations and patient outcomes.
First Author: Fern Anari
Poster
2016 Genitourinary Cancers Symposium
Integrated whole exome and RNA sequencing to reveal distinct genomic and transcriptomic landscape of upper tract urothelial carcinoma.
First Author: Bishoy Faltas